265 related articles for article (PubMed ID: 17234761)
21. Haploinsufficiency of Runx1/AML1 promotes myeloid features and leukaemogenesis in BXH2 mice.
Yamashita N; Osato M; Huang L; Yanagida M; Kogan SC; Iwasaki M; Nakamura T; Shigesada K; Asou N; Ito Y
Br J Haematol; 2005 Nov; 131(4):495-507. PubMed ID: 16281942
[TBL] [Abstract][Full Text] [Related]
22. Physical and functional interaction of Runt-related protein 1 with hypoxia-inducible factor-1alpha.
Peng ZG; Zhou MY; Huang Y; Qiu JH; Wang LS; Liao SH; Dong S; Chen GQ
Oncogene; 2008 Jan; 27(6):839-47. PubMed ID: 17684492
[TBL] [Abstract][Full Text] [Related]
23. Runx1 promotes B-cell survival and lymphoma development.
Blyth K; Slater N; Hanlon L; Bell M; Mackay N; Stewart M; Neil JC; Cameron ER
Blood Cells Mol Dis; 2009; 43(1):12-9. PubMed ID: 19269865
[TBL] [Abstract][Full Text] [Related]
24. Acceleration of G(1) cooperates with core binding factor beta-smooth muscle myosin heavy chain to induce acute leukemia in mice.
Yang Y; Wang W; Cleaves R; Zahurak M; Cheng L; Civin CI; Friedman AD
Cancer Res; 2002 Apr; 62(8):2232-5. PubMed ID: 11956074
[TBL] [Abstract][Full Text] [Related]
25. Thermodynamic investigation of DNA-binding affinity of wild-type and mutant transcription factor RUNX1.
Wu F; Song T; Yao Y; Song Y
PLoS One; 2019; 14(5):e0216203. PubMed ID: 31048839
[TBL] [Abstract][Full Text] [Related]
26. Runx1/Cbfβ2 complexes are required for lymphoid tissue inducer cell differentiation at two developmental stages.
Tachibana M; Tenno M; Tezuka C; Sugiyama M; Yoshida H; Taniuchi I
J Immunol; 2011 Feb; 186(3):1450-7. PubMed ID: 21178013
[TBL] [Abstract][Full Text] [Related]
27. Expression of AML/Runx and ETO/MTG family members during hematopoietic differentiation of embryonic stem cells.
Okumura AJ; Peterson LF; Lo MC; Zhang DE
Exp Hematol; 2007 Jun; 35(6):978-88. PubMed ID: 17533052
[TBL] [Abstract][Full Text] [Related]
28. Downregulation of RUNX1/CBFβ by MLL fusion proteins enhances hematopoietic stem cell self-renewal.
Zhao X; Chen A; Yan X; Zhang Y; He F; Hayashi Y; Dong Y; Rao Y; Li B; Conway RM; Maiques-Diaz A; Elf SE; Huang N; Zuber J; Xiao Z; Tse W; Tenen DG; Wang Q; Chen W; Mulloy JC; Nimer SD; Huang G
Blood; 2014 Mar; 123(11):1729-38. PubMed ID: 24449215
[TBL] [Abstract][Full Text] [Related]
29. Retroviral insertional mutagenesis identifies RUNX genes involved in chronic myeloid leukemia disease persistence under imatinib treatment.
Miething C; Grundler R; Mugler C; Brero S; Hoepfl J; Geigl J; Speicher MR; Ottmann O; Peschel C; Duyster J
Proc Natl Acad Sci U S A; 2007 Mar; 104(11):4594-9. PubMed ID: 17360569
[TBL] [Abstract][Full Text] [Related]
30. Novel loss-of-function mutations of the haematopoiesis-related transcription factor, acute myeloid leukaemia 1/runt-related transcription factor 1, detected in acute myeloblastic leukaemia and myelodysplastic syndrome.
Nakao M; Horiike S; Fukushima-Nakase Y; Nishimura M; Fujita Y; Taniwaki M; Okuda T
Br J Haematol; 2004 Jun; 125(6):709-19. PubMed ID: 15180860
[TBL] [Abstract][Full Text] [Related]
31. The Runx1 transcription factor controls CSF-1-dependent and -independent growth and survival of macrophages.
Himes SR; Cronau S; Mulford C; Hume DA
Oncogene; 2005 Aug; 24(34):5278-86. PubMed ID: 16007221
[TBL] [Abstract][Full Text] [Related]
32. C-terminal mutation of RUNX1 attenuates the DNA-damage repair response in hematopoietic stem cells.
Satoh Y; Matsumura I; Tanaka H; Harada H; Harada Y; Matsui K; Shibata M; Mizuki M; Kanakura Y
Leukemia; 2012 Feb; 26(2):303-11. PubMed ID: 21836608
[TBL] [Abstract][Full Text] [Related]
33. Molecular mechanisms that produce secondary MDS/AML by RUNX1/AML1 point mutations.
Harada Y; Harada H
J Cell Biochem; 2011 Feb; 112(2):425-32. PubMed ID: 21268063
[TBL] [Abstract][Full Text] [Related]
34. Runx1 selectively regulates cell fate specification and axonal projections of dorsal root ganglion neurons.
Yoshikawa M; Senzaki K; Yokomizo T; Takahashi S; Ozaki S; Shiga T
Dev Biol; 2007 Mar; 303(2):663-74. PubMed ID: 17208218
[TBL] [Abstract][Full Text] [Related]
35. DNA-binding dependent and independent functions of WT1 protein during human hematopoiesis.
Svensson E; Eriksson H; Gekas C; Olofsson T; Richter J; Gullberg U
Exp Cell Res; 2005 Aug; 308(1):211-21. PubMed ID: 15907324
[TBL] [Abstract][Full Text] [Related]
36. Cbfbeta reduces Cbfbeta-SMMHC-associated acute myeloid leukemia in mice.
Heilman SA; Kuo YH; Goudswaard CS; Valk PJ; Castilla LH
Cancer Res; 2006 Dec; 66(23):11214-8. PubMed ID: 17145866
[TBL] [Abstract][Full Text] [Related]
37. Impaired hematopoietic differentiation of RUNX1-mutated induced pluripotent stem cells derived from FPD/AML patients.
Sakurai M; Kunimoto H; Watanabe N; Fukuchi Y; Yuasa S; Yamazaki S; Nishimura T; Sadahira K; Fukuda K; Okano H; Nakauchi H; Morita Y; Matsumura I; Kudo K; Ito E; Ebihara Y; Tsuji K; Harada Y; Harada H; Okamoto S; Nakajima H
Leukemia; 2014 Dec; 28(12):2344-54. PubMed ID: 24732596
[TBL] [Abstract][Full Text] [Related]
38. RUNX1 suppression induces megakaryocytic differentiation of UT-7/GM cells.
Nagai R; Matsuura E; Hoshika Y; Nakata E; Nagura H; Watanabe A; Komatsu N; Okada Y; Doi T
Biochem Biophys Res Commun; 2006 Jun; 345(1):78-84. PubMed ID: 16674921
[TBL] [Abstract][Full Text] [Related]
39. Biological Activities of RUNX1 Mutants Predict Secondary Acute Leukemia Transformation from Chronic Myelomonocytic Leukemia and Myelodysplastic Syndromes.
Tsai SC; Shih LY; Liang ST; Huang YJ; Kuo MC; Huang CF; Shih YS; Lin TH; Chiu MC; Liang DC
Clin Cancer Res; 2015 Aug; 21(15):3541-51. PubMed ID: 25840971
[TBL] [Abstract][Full Text] [Related]
40. Two clonal occurrences of tetrasomy 21 in an atypical chronic myeloid leukemia with wild-type RUNX1 alleles. Additional support for a gene dosage effect of chromosome 21 or RUNX1 in leukemia.
Escher R; Mühlematter D; Scott HS; Jotterand M; Tobler A
Haematologica; 2004 Aug; 89(8):ECR26. PubMed ID: 15339695
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
